Researcher Profile

Jean-Pierre Delord

🏛 7Institut Claudius Regaud, Toulouse, France.

0000-0001-7305-5561

Publications

5,100

Citations

Co-Authors

Active Years

Publications

Journal Article Innovations & Thérapeutiques en Oncologie Mar 01, 2026

Développement des vaccins thérapeutiques en oncologie : de l’activation immunitaire aux succès cliniques

Caroline Fournier · Jean-Pierre Delord

10.1684/ito.2026.575

Journal Article Investigational New Drugs May 14, 2020

A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment

Jean-Pierre Delord · Guillem Argiles · Jerome Fayette · Lori Wirth +13 more

10.1007/s10637-020-00928-z 21 citations

Journal Article Cancer Immunology Research Jul 01, 2020

Dual Relief of T-lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial Malignancies

Camille-Charlotte Balança · Clara-Maria Scarlata · Marie Michelas · Christel Devaud +27 more

10.1158/2326-6066.cir-19-0855 21 citations

Journal Article Journal of Clinical Oncology Jan 01, 2020

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

Aurelien Marabelle · Dung T. Le · Paolo A. Ascierto · Anna Maria Di Giacomo +18 more

10.1200/jco.19.02105 2,558 citations

Journal Article The Lancet Oncology Sep 01, 2020

Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study

Susan M Domchek · Sophie Postel-Vinay · Seock-Ah Im · Yeon Hee Park +21 more

10.1016/s1470-2045(20)30324-7 417 citations

Journal Article Journal of Clinical Oncology Nov 01, 2019

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

R. Wendel Naumann · Antoine Hollebecque · Tim Meyer · Michael-John Devlin +15 more

10.1200/jco.19.00739 387 citations

Journal Article The Lancet Jan 01, 2019

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E W Cohen · Denis Soulières · Christophe Le Tourneau · José Dinis +99 more

10.1016/s0140-6736(18)31999-8 1,449 citations

Journal Article Journal of Clinical Oncology May 20, 2018

Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with anaplastic thyroid cancer.

Lori J. Wirth · Ekkehard Eigendorff · Jaume Capdevila · Luis G. Paz-Ares +14 more

10.1200/jco.2018.36.15_suppl.6024 41 citations

Journal Article Cancer Discovery Jun 01, 2017

A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic BRAF -Mutant Colorectal Cancer

Robin M.J.M. van Geel · Josep Tabernero · Elena Élez · Johanna C. Bendell +19 more

10.1158/2159-8290.cd-16-0795 206 citations

Publication Timeline

2026

2020

2019

2018

2017

Frequent Co-Authors

2×

2×

1×

1×

1×

1×

1×

1×

1×

1×